Acima Private Wealth LLC Sells 486 Shares of Colgate-Palmolive Company $CL

Acima Private Wealth LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 19.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000 shares of the company’s stock after selling 486 shares during the quarter. Acima Private Wealth LLC’s holdings in Colgate-Palmolive were worth $182,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Westend Capital Management LLC lifted its position in Colgate-Palmolive by 111.1% during the 1st quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock worth $25,000 after buying an additional 140 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in Colgate-Palmolive by 1,913.3% during the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock worth $28,000 after buying an additional 287 shares in the last quarter. Saudi Central Bank bought a new stake in Colgate-Palmolive during the 1st quarter worth about $29,000. Ransom Advisory Ltd bought a new stake in Colgate-Palmolive during the 1st quarter worth about $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new stake in Colgate-Palmolive during the 1st quarter worth about $37,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Up 0.2%

Shares of CL opened at $77.99 on Friday. Colgate-Palmolive Company has a 52 week low of $77.09 and a 52 week high of $102.61. The firm has a market cap of $63.03 billion, a P/E ratio of 21.91, a price-to-earnings-growth ratio of 4.28 and a beta of 0.34. The firm’s 50-day simple moving average is $82.56 and its 200 day simple moving average is $87.91. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 EPS. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive’s payout ratio is currently 58.43%.

Analyst Ratings Changes

Several equities research analysts have commented on CL shares. JPMorgan Chase & Co. cut their price target on shares of Colgate-Palmolive from $95.00 to $88.00 and set an “overweight” rating on the stock in a research report on Friday. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. UBS Group lowered their price objective on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research note on Wednesday. The Goldman Sachs Group lowered their price objective on shares of Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Finally, Piper Sandler initiated coverage on shares of Colgate-Palmolive in a research note on Friday, October 3rd. They set a “neutral” rating and a $84.00 price objective on the stock. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.